Have a personal or library account? Click to login
An example of anti-JMH with characteristics of a clinically significant antibody Cover

An example of anti-JMH with characteristics of a clinically significant antibody

By: J. Geisland,  M. Corgan and  B. Hillard  
Paid access
|Dec 2020

References

  1. Sabo B, Moulds JJ, McCreary J. Anti-JMH: another high titer-low avidity antibody against a high frequency antigen (abstract). Transfusion 1978;18:387.
  2. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 8th ed. Oxford: Blackwell Scientific Publications, 1987:404.
  3. Issitt PD. Applied blood group serology. 3rd ed. Miami: Montgomery Scientific Publications, 1985:433–5.
  4. Baldwin ML, Ness PM, Barrasso C, et al. In vivo studies of the long-term 51 Cr red cell survival of serologically incompatible red cells units. Transfusion 1985;25:34–8.10.1046/j.1537-2995.1985.25185116499.x
  5. Judd WJ. Methods in immunohematology. Miami: Montgomery Scientific Publications, 1988:171–2.
  6. Widmann FK, ed. Technical manual. 9th ed. Arlington, VA: American Association of Blood Banks, 1985:202-8, 234-40.
  7. Melvin JR, Sanfilippo JS, Dobra KW, Cronholm LS, Maldonado WE. An improved method of acid elution and its application in obstetric and pediatric immunohematology. Am J Obstet Gynecol 1981;141:25–8.10.1016/0002-9378(81)90670-0
  8. Garratty G. Predicting the clinical significance of alloantībodies and determining the in vivo survival of transfused red cells. In: Judd WJ, Barnes A, eds. Clinical and serological aspects of transfusion reactions. Arlington VA: American Association of Blood Banks, 1982:91–119.
  9. Zupanska B, Thomson EE, Merry AH. Fc receptors for IgG1 and IgG3 on human mononuclear cells—an evaluation with known levels of erythrocyte-bound IgG. Vox Sang 1986;50:97–103.
  10. Zupanska B, Thompson E, Brojer E, Merry AH. Phagocytosis of erythrocytes sensitized with known amounts of IgGl and IgG3 anti-Rh antibodies. Vox Sang 1987;53:96–101.10.1111/j.1423-0410.1987.tb04926.x3120411
  11. Wiehier E, Atwal A, Thompson KM, Melamed MD, Gorick B, Hughes-Jones NC. Differences between the activities of human monoclonal IgG1 and IgG3 subclasses of anti-D (Rh) antibody in their ability to mediate red cell-binding to macrophages. Immunology 1987;62:401–4.
  12. Wiener E, Jolliffe VM, Scott HCF, et al. Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes. Immunology 1988;65:159–63.
  13. Ukita M, Takahashi A, Nunotani T, Kihana T, Watanabe S, Yamada N. IgG subclasses of anti-A and anti-B antibodies bound to the cord blood red cells in ABO incompatible pregnancies. Vox Sang 1989;56:181–6.10.1111/j.1423-0410.1989.tb02023.x2728395
  14. Engelfriet CP. Immune destruction of red cells. In: Bell CA, ed. A seminar on immune-mediated cell destruction. Washington, DC: American Association of Blood Banks, 1981.
  15. Schanfield MS, Stevens JO, Bauman D. The detection of clinically significant erythrocyte alloantībodies using a human mononuclear phagocyte assay. Transfusion 1981;21:571–6.10.1046/j.1537-2995.1981.21582040822.x6794195
  16. Nance S, Garratty G. Correlations between an in vitro monocyte monolayer assay and autoimmune hemolytic anemia (AIHA) (abstract). Transfusion 1982;22:410.
DOI: https://doi.org/10.21307/immunohematology-2019-1031 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 9 - 11
Published on: Dec 20, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 J. Geisland, M. Corgan, B. Hillard, published by American National Red Cross
This work is licensed under the Creative Commons License.